This study tests whether adding an experimental drug called indoximod to standard chemotherapy and radiation can help children aged 3 to 21 with certain brain cancers. The drug aims to boost the body's immune system to fight tumors more effectively. The trial includes children wi…
Phase: PHASE2 • Sponsor: Theodore S. Johnson • Aim: Disease control
Last updated Jun 16, 2026 12:52 UTC